Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Mitochondrial Cause of Aging Can Be Reversed

By LabMedica International staff writers
Posted on 07 Jan 2014
Researchers have found a cause of aging in lab animals that can be reversed, possibly providing an avenue for new treatments for age-related diseases including type 2 diabetes, cancer, muscle wasting, and inflammatory diseases. More...


The researchers plan to begin human trials late 2014. The study, which was published December 19, 2013, in the journal Cell, relates to mitochondria.

The research led by geneticist David Sinclair from Harvard Medical School (Boston, MA, USA) discovered a sequence of molecular events that enable communication inside cells between the mitochondria and the nucleus. As communication breaks down, aging accelerates. “The aging process we discovered is like a married couple—when they are young, they communicate well, but over time, living in close quarters for many years, communication breaks down,” stated Prof. Sinclair. “And just like a couple, restoring communication solved the problem.”

The hypothesis behind the research is that as humans age, levels of the chemical nicotinamide adenine dinucleotide (NAD), which begins this communication cascade, decline. Until now, the only way to suppress the NAD decline was to curb calories and exercise intensively. In this study, the researchers used a compound that cells convert into NAD to repair the broken network and rapidly restore communication and mitochondrial function. It mimics the effects of diet and exercise.

While Prof. Sinclair’s group in Boston was working on muscles in tissue culture, colleagues from the University of New South Wales (UNSW; Sydney; Australia) were working on animal models to validate the research that could have the same findings. “It was shocking how quickly it happened,” said coauthor Dr. Nigel Turner, from UNSW’s department of pharmacology. “If the compound is administered early enough in the aging process, in just a week, the muscles of the older mice were indistinguishable from the younger animals.”

The mice, which were two-years-old, also performed well on insulin resistance and inflammation—both of which are correlated with aging. They were compared with six-month-old animals. “It was a very pronounced effect,” stated Dr. Turner. “It’s something like a 60-year-old being similar to a 20-year-old on some measures.” The younger mice given the same compound were “supercharged above normal level” on certain measures, according to Dr. Turner. “So it is possible this would have benefits in healthy, young humans.”

One notably significant facet of this research involves HIF-1, which is an intrusive molecule that foils communication, but also has a role in cancer. It has been known for some time that HIF-1 is turned on in many cancers, now this research has found it also switches on during aging. “We become cancer-like in our aging process,” noted Prof. Sinclair. “Nobody has linked cancer and aging like this before.” This may clarify why the greatest risk of cancer is age.

The researchers are now examining the longer-term outcomes the NAD-generating substance has on mice. They are exploring whether it can be used to safely treat rare mitochondrial diseases and other conditions, such as type 1 and type 2 diabetes, as well as for longevity and good health.

Prof. Sinclair and his group have been studying the fundamental science of aging for many years, primarily focusing on a group of genes called sirtuins. Earlier research from his laboratory had demonstrated that one of these genes, SIRT1, was activated by the naturally occurring compound resveratrol (found in small amounts in grapes, red wine, and various nuts).

The latest research goes further, as it triggers all seven of the sirtuin genes. “There’s clearly much more work to be done here, but if those results stand, then aging may be a reversible condition, if it is caught early,” concluded Prof. Sinclair.

Related Links:

Harvard University Medical School
University of New South Wales



New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Rapid Molecular Testing Device
FlashDetect Flash10
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.